COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA (CAP) explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA (CAP) trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Herbal formula NRICM102 tested as pneumonia Add-On treatment
Disease control Not yet recruitingThis Phase 2 trial tests whether NRICM102, a Traditional Chinese Medicine, can help adults with community-acquired pneumonia reach clinical stability faster when added to standard antibiotic therapy. About 150 hospitalized participants will take either NRICM102 or a placebo for 7…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE2 • Sponsor: National Research Institute of Chinese Medicine, Ministry of Health and Welfare • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New peptide drug aims to tame sepsis in pneumonia patients
Disease control Not yet recruitingThis early-stage trial tests a drug called OPT101 in 26 adults hospitalized with pneumonia and sepsis. The drug is designed to reduce harmful inflammation. The main goal is to check safety and how the body processes the drug, not yet to prove it works.
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC
-
Could your Child's cough help diagnose asthma or pneumonia?
Diagnosis Not yet recruitingThis study will collect cough sounds, breath sounds, and symptom questionnaires from 1,400 children with respiratory symptoms like cough or fever. Researchers will use this data to build a computer model that can help diagnose conditions like asthma and pneumonia. The goal is to …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Sponsor: Shanghai Children's Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Could less be more? new trial tests lower antibiotic dose for pneumonia
Symptom relief Not yet recruitingThis study compares two doses of the antibiotic ceftriaxone for adults hospitalized with pneumonia (but not in the ICU). The goal is to see if a 1-gram daily dose works just as well as a 2-gram daily dose while causing fewer side effects. About 430 participants will be followed t…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New genetic test aims to solve stubborn pneumonia cases
Knowledge-focused Not yet recruitingThis study looks at whether a special genetic test (tNGS) can help doctors treat hospitalized adults with pneumonia that isn't responding to first antibiotics. About 524 participants will be randomly assigned to get the test or standard care. The main goal is to see if the test s…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Capital Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC